Self-sampling device to be sent automatically, making it easier to take part in cervical cancer screening From the first week of July, every woman turning 30 will receive a self-sampling device with their invitation for cervical cancer screening. Participants can use this device to collect their own vaginal material.
No major change in air quality in the Netherlands in 2022 The overall air quality in 2022 was slightly worse than in 2021. Weather conditions such as temperature and drought played an important role in this difference. This is according to the large-scale concentration maps published by RIVM each year.
Aura Timen named Professor by special appointment at VU Amsterdam Aura Timen has been named Professor by special appointment to the chair of 'Responses to communicable diseases in global health' as of June 1st 2018.
National Heat Plan no longer in effect As of Wednesday, August 8th 2018, the National Heat Plan is no longer in effect. The temperatures will be lower as of Wednesday.
Health and Well-being through Effective Blue-Green Space Design and Governance During World Water Week (August 26 – 31, 2018), the Dutch National Institute for Public Health and the Environment, RIVM, is facilitating a session on Health and Well-being through effective Blue-G
National Heat Plan active for parts of the Netherlands On August 2, 2018, the National Heat Plan has been activated for the provinces Limburg, Noord-Brabant, Gelderland, Utrecht, Overijssel and Drenthe.
RIVM welcomes German Federal Centre for Health Education Today RIVM’s Centre for Healthy Living (CGL) welcomes the Bundeszentrale für gesundheitliche Aufklärung.
Scientific background information on rubber granulate now available in English In December 2016, RIVM published in Dutch the results of its research into the health risks of playing sports on synthetic turf pitches with rubber granulate.
Environmentally harmful pharmaceuticals cannot be replaced yet RIVM investigates how the impact of pharmaceutical residues on the environment may be reduced.
Off-label use of medicinal products in the European Union Off-label use of medicinal products in the European Union is common, both in primary and in secondary care.